Pharsight

Lumify generic

Lumify is an eye redness reliever owned by Bausch And Lomb Inc. brimonidine tartrate, its active ingredient, was first authorized for market use on 22 December, 2017.

When will Lumify generic be available?

The generic version of Lumify might become available after 14 July, 2030. This is due to its last patent, 'Preferential vasoconstriction compositions and methods of use', set to expire on that date.

Lumify uses

Lumify relieves redness of the eye due to minor eye irritations. Its active ingredient, brimonidine tartrate, is a highly effective agent in relieving these symptoms.

Lumify patent expiration

Lumify holds three patents, with the latest one - 'Preferential vasoconstriction compositions and methods of use' - set to expire on 14 July, 2030. Because of this, the Lumify generic might not be available until after this date. Below are the details of the patent:

Litigations filed on Lumify

Lumify dosage

Want to ask something?